{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:03:25Z","timestamp":1793113405454,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Nocturnal blood pressure is difficult to manage in clinical practice. Antihypertensive chronotherapy may offer a potential approach for better control. However, the clinical evidence supporting this approach remains controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the effects of morning vs bedtime antihypertensive medication administration on nocturnal blood pressure reduction and circadian rhythm among patients with hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      This randomized clinical trial was conducted at 15 hospitals in China from June 1, 2022, to April 30, 2024, with a 12-week follow-up. Patients with hypertension without prior antihypertensive treatment or who had discontinued antihypertensive agents for 2 weeks were randomized to the morning (6:00-10:00\n                      <jats:sc>am<\/jats:sc>\n                      ) or bedtime (6:00-10:00\n                      <jats:sc>pm<\/jats:sc>\n                      ) dosing group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Patients received a single pill containing olmesartan, 20 mg, and amlodipine, 5 mg, daily for 12 weeks, with dosage adjustments based on ambulatory and office blood pressure measurements at week 4 and week 8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the change in nighttime systolic blood pressure from baseline to 12 weeks. Key secondary outcomes included changes in office and other ambulatory blood pressure indicators. The primary and secondary outcomes were analyzed in the intention-to-treat and the per-protocol populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 720 patients (mean [SD] age, 55.5 [10.6] years; 409 men [56.8%]) were randomized to morning (n\u2009=\u2009352) or bedtime (n\u2009=\u2009368) dosing groups. The mean (SD) baseline blood pressure values for morning vs bedtime dosing at 24 hours were 148.0 (11.1)\/91.4 (9.0) mm Hg vs 147.6 (11.0)\/91.6 (9.2) mm Hg, for daytime were 152.3 (11.0)\/94.0 (9.2) mm Hg vs 151.5 (11.6)\/94.0 (9.8) mm Hg, for nighttime were 138.4 (15.1)\/85.4 (10.4) mm Hg vs 138.3 (13.0)\/85.8 (9.4) mm Hg, and in the office were 154.4 (12.1)\/94.6 (10.3) mm Hg vs 154.3 (12.5)\/95.1 (11.1) mm Hg. Compared with patients in the morning dosing group, those in the bedtime dosing group showed significantly greater reductions in nighttime systolic blood pressure (between-group difference, \u22123.0 mm Hg [95% CI, \u22125.1 to \u22121.0 mm Hg];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.004), and nighttime diastolic blood pressure (between-group difference, \u22121.4 mm Hg [95% CI, \u22122.8 to \u22120.1 mm Hg];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.04), with better nocturnal systolic blood pressure control (79.0% [244 of 309] vs 69.8% [208 of 298];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01) and improved circadian rhythm. The incidence of nocturnal hypotension did not differ.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial of antihypertensive chronotherapy, bedtime dosing provided better control of nocturnal blood pressure and improved the circadian rhythm, without reducing the efficacy on mean daytime or 24-hour blood pressure, or increasing the risk of nocturnal hypotension. These findings support the potential advantages of bedtime administration and offer new evidence to guide future research on antihypertensive chronotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.html?proj=169782\">ChiCTR2200059719<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.19354","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T15:00:41Z","timestamp":1752073241000},"page":"e2519354","source":"Crossref","is-referenced-by-count":29,"title":["Morning vs Bedtime Dosing and Nocturnal Blood Pressure Reduction in Patients With Hypertension"],"prefix":"10.1001","volume":"8","author":[{"given":"Runyu","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghao","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhuo","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtao","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufeng","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Ran","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chengdu Seventh People\u2019s Hospital, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical Treatment Alliance of West China Hospital, Sichuan University and Qinglong Community Healthcare Center, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Gao","sequence":"additional","affiliation":[{"name":"Medical Treatment Alliance of West China Hospital, Sichuan University and Qinglong Community Healthcare Center, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Treatment Alliance of West China Hospital, Sichuan University and Jiulong County People\u2019s Hospital, Jiulong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Treatment Alliance of West China Hospital, Sichuan University and Luhuo County People\u2019s Hospital, Luhuo, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanchong Central Hospital and Affiliation of Beijing Anzhen Hospital, Capital Medical University, Nanchong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ma","sequence":"additional","affiliation":[{"name":"Medical Treatment Alliance of West China Hospital, Sichuan University and Shuangqiaozi Community Healthcare Center, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second People\u2019s Hospital of Yibin and Yibin Affiliated Hospital of West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuanqin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical Treatment Alliance of West China Hospital, Sichuan University and Litang County People\u2019s Hospital, Litang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chongzhou People\u2019s Hospital, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"10258","key":"zoi250601r1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"10304","key":"zoi250601r2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"zoi250601r3","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"issue":"1","key":"zoi250601r4","first-page":"24","article-title":"2018 Chinese guidelines for the management of hypertension.","volume":"24","author":"Revision Committee of Guidelines on the Management of Hypertension in China","year":"2019","journal-title":"Chin J Cardiovasc Med"},{"issue":"12","key":"zoi250601r5","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s12272-014-0446-x","article-title":"Efficacy and safety of olmesartan medoxomil\/amlodipine fixed-dose combination for hypertensive patients uncontrolled with monotherapy.","volume":"37","author":"Zhu","year":"2014","journal-title":"Arch Pharm Res"},{"issue":"10393","key":"zoi250601r6","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(23)00733-X","article-title":"Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59?124 patients.","volume":"401","author":"Staplin","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"zoi250601r7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.ajkd.2022.04.010","article-title":"Dipping status, ambulatory blood pressure control, cardiovascular disease, and kidney disease progression: a multicenter cohort study of CKD.","volume":"81","author":"Borrelli","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"zoi250601r8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jama.2019.9811","article-title":"Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes.","volume":"322","author":"Yang","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"zoi250601r9","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1038\/s41440-023-01336-5","article-title":"Control status of ambulatory blood pressure and its relationship with arterial stiffness in the China nationwide registry of treated hypertensive patients: the REACTION-ABP study.","volume":"46","author":"Li","year":"2023","journal-title":"Hypertens Res"},{"issue":"10","key":"zoi250601r10","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/jch.12589","article-title":"Nocturnal hypertension correlates better with target organ damage in patients with chronic kidney disease than a nondipping pattern.","volume":"17","author":"Wang","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"02","key":"zoi250601r11","first-page":"104","article-title":"Chinese expert recommendations on high-quality blood pressure management in hypertensive patients.","volume":"32","author":"Chinese Hypertension League","year":"2024","journal-title":"Chin J Hypertens."},{"issue":"48","key":"zoi250601r12","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1093\/eurheartj\/ehz754","article-title":"Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.","volume":"41","author":"Hermida","year":"2020","journal-title":"Eur Heart J"},{"issue":"7","key":"zoi250601r13","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/HYPERTENSIONAHA.122.20862","article-title":"Timing of antihypertensive drug therapy: a systematic review and meta-analysis of randomized clinical trials.","volume":"80","author":"Maqsood","year":"2023","journal-title":"Hypertension"},{"issue":"2","key":"zoi250601r14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/HJH.0000000000003581","article-title":"Impact of timing of antihypertensive treatment on mortality: an observational study from the Spanish Ambulatory Blood Pressure Monitoring Registry.","volume":"42","author":"de la Sierra","year":"2024","journal-title":"J Hypertens"},{"issue":"4","key":"zoi250601r15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/HYPERTENSIONAHA.118.11101","article-title":"Randomized crossover trial of the impact of morning or evening dosing of antihypertensive agents on 24-hour ambulatory blood pressure.","volume":"72","author":"Poulter","year":"2018","journal-title":"Hypertension"},{"issue":"10361","key":"zoi250601r16","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(22)01786-X","article-title":"Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial.","volume":"400","author":"Mackenzie","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"zoi250601r17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11906-020-1032-x","article-title":"New insights on chronotherapy in hypertension: is timing everything?","volume":"22","author":"Thoonkuzhy","year":"2020","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"zoi250601r18","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1097\/HJH.0000000000003240","article-title":"Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.","volume":"40","author":"Stergiou","year":"2022","journal-title":"J Hypertens"},{"issue":"1","key":"zoi250601r20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s13063-023-07726-x","article-title":"The effects of olmesartan\/amlodipine administered in the morning or at night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial.","volume":"24","author":"Xu","year":"2023","journal-title":"Trials"},{"issue":"3","key":"zoi250601r21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/jch.14128","article-title":"Guidance on ambulatory blood pressure monitoring: a statement from the HOPE Asia Network.","volume":"23","author":"Kario","year":"2021","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"04","key":"zoi250601r22","first-page":"313","article-title":"2020 Chinese Hypertension League guidelines on ambulatory blood pressure monitoring.","volume":"36","author":"Writing Group of the 2020 Chinese Hypertension League Guidelines on Ambulatory Blood Pressure Monitoring","year":"2021","journal-title":"Chinese Circulation Journal."},{"issue":"04","key":"zoi250601r23","first-page":"316","article-title":"Expert consensus on the effectiveness evaluation of clinical trials of oral antihypertensive drugs in China.","volume":"23","author":"Yuan","year":"2015","journal-title":"Chin J Hypertens"},{"issue":"2","key":"zoi250601r24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/HYPERTENSIONAHA.121.17356","article-title":"Missing verification of source data in hypertension research: the HYGIA PROJECT in perspective.","volume":"78","author":"Brunstr\u00f6m","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"zoi250601r25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/08037051.2020.1747696","article-title":"Blood pressure medication should not be routinely dosed at bedtime: we must disregard the data from the HYGIA project.","volume":"29","author":"Kreutz","year":"2020","journal-title":"Blood Press"},{"issue":"10285","key":"zoi250601r26","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis.","volume":"397","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2021","journal-title":"Lancet"},{"issue":"9349","key":"zoi250601r27","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"zoi250601r28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/HJH.0000000000000397","article-title":"Time of administration important?: morning versus evening dosing of valsartan.","volume":"33","author":"Zappe","year":"2015","journal-title":"J Hypertens"},{"issue":"1","key":"zoi250601r29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/HYPERTENSIONAHA.109.130203","article-title":"Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing.","volume":"54","author":"Hermida","year":"2009","journal-title":"Hypertension"},{"issue":"11","key":"zoi250601r30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11906-018-0897-4","article-title":"Chronotherapy for hypertension.","volume":"20","author":"Bowles","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"zoi250601r31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/abm\/kaaa042","article-title":"Time-of-day differences in treatment-related habit strength and adherence.","volume":"55","author":"Phillips","year":"2021","journal-title":"Ann Behav Med"},{"issue":"6","key":"zoi250601r32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/10641963.2017.1411493","article-title":"Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: a pilot study to assess feasibility and efficacy in chronic kidney disease patients.","volume":"40","author":"Smith","year":"2018","journal-title":"Clin Exp Hypertens"},{"issue":"04","key":"zoi250601r33","first-page":"316","article-title":"Expert consensus of young and middle-aged hypertension management in China. Article in Chinese.","volume":"28","author":"Liu","year":"2020","journal-title":"Chin J Hypertens"},{"issue":"9","key":"zoi250601r34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jash.2016.06.035","article-title":"Hypotension based on office and ambulatory monitoring blood pressure: prevalence and clinical profile among a cohort of 70,997 treated hypertensives.","volume":"10","author":"Divis\u00f3n-Garrote","year":"2016","journal-title":"J Am Soc Hypertens"},{"issue":"9","key":"zoi250601r35","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/ajh\/hpz074","article-title":"Extreme dipping: always means nocturnal hypotension?","volume":"32","author":"Cuspidi","year":"2019","journal-title":"Am J Hypertens"},{"key":"zoi250601r19","unstructured":"Urbaniak? GC, Plous? S. Research Randomizer. Version 4.0. June 22, 2013. Accessed May 20, 2025. http:\/\/www.randomizer.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2836172\/ye_2025_oi_250601_1751315701.02267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T15:00:43Z","timestamp":1752073243000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2836172"}},"subtitle":["The OMAN Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.19354","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}